Publication year
2017Source
Pediatric Blood & Cancer, 64, 3, (2017), pp. UNSP e26230, article UNSP e26230ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Paediatrics
Paediatrics - OUD tm 2017
Human Genetics
Journal title
Pediatric Blood & Cancer
Volume
vol. 64
Issue
iss. 3
Page start
p. UNSP e26230
Page end
p. UNSP e26230
Subject
Radboudumc 0: Other Research RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life Sciences; Human Genetics Radboud University Medical CenterAbstract
Transient myeloproliferative disorder (TMD) is a leukemia type that occurs typically in newborns. In Down syndrome, TMD is referred to as transient abnormal myelopoiesis (TAM).32 Recently, transientness has also been reported in acute myeloid leukemia patients with germline trisomy 21 mosaicism, and even in cases with somatic trisomy 21, with or without GATA1 mutations. TMD cases without trisomy 21 are rare, and recurrent genetic aberrations that aid in clinical decision-making are scarcely described. We describe here a TMD patient without trisomy 21 or GATA1 mutation in whom single-nucleotide polymorphism analysis of leukemic blasts revealed a novel combined submicroscopic deletion (5q31.1-5q31.3 and 8q23.2q24).
This item appears in the following Collection(s)
- Academic publications [248471]
- Faculty of Medical Sciences [94202]
Upload full text
Use your RU or RadboudUMC credentials to log in with SURFconext to upload a file for processing by the repository team.